The conductor and his orchestra

Drug Discovery Today

Volumn 13, Issue 7-8, 2008, Pages 281-284

  Lewi, Paul J ^a  

^a NONE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIDIARRHEAL AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIPARASITIC AGENT; CARDIOVASCULAR AGENT; ETRAVIRINE; HALOPERIDOL; ITRACONAZOLE; MICONAZOLE; NEUROLEPTIC AGENT; PROKINETIC AGENT; RISPERIDONE; SPASMOLYTIC AGENT;

ALLERGY; ANALGESIA; CARDIOVASCULAR DISEASE; DECISION MAKING; DRUG INDUSTRY; DRUG MANUFACTURE; EDUCATION; GASTROINTESTINAL DISEASE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN FACTORS RESEARCH; INSURANCE; MEDICAL RESEARCH; MEDICINE; MUSIC; MYCOSIS; NONHUMAN; PAIN; PARASITOSIS; PSYCHIATRY; PSYCHOSIS; SCIENTIST; SHORT SURVEY;

DRUG DESIGN; DRUG INDUSTRY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; LEADERSHIP; PHARMACEUTICAL PREPARATIONS; RESEARCH;

EID: 41549131597     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2008.02.008     Document Type: Short Survey

References (22)

1. Schwartz H. Breakthrough. The Discovery of Modern Medicines at Janssen (1989), Skyline Publ. Group
2. Janssen P. A personal memoir. CINP (Collegium Internationale Neuro-Psychopharmacologicum) Newsletter Fall (2000) 22-25
3. Smith A. Fuelling the pipeline. Nat. Rev. Drug Disc. 1 (2002) 167
4. Black J. Dr. Paul Janssen. J. Med. Chem. 48 (2005) 1687-1688
5. Smith A. The conductorless orchestra. Nat. Rev. Drug Disc. 3 (2004) 3
6. Van Gestel S., and Schuermans V. Thirty-three years of drug discovery and research with Dr. Paul Janssen. Drug Dev. Res. 8 (1986) 1-13
7. Reyntjens A., and Van Reet S. Success factors of Janssen research. Drug News Persp. 4 (1991) 185-190
8. Janssen, P. (2002) The decrease in the number of farmers has led to less common sense. Interview with Kirsten Bett. ECNP (European College of Neuropsychopharmacology) Newsletter No 2, January, pp. 1-4 http://ecnp.i-site.nl/Matters/number2/PaulJanssen.htm
9. Black J. Future perspectives in pharmaceutical research. Pharmacol. Policy Law 1 (1999) 85-92
10. Uitdehaag J.C.M. Where is the optimism? Warrior teachings to regain the drug discovery spirit. Drug Disc. Today 12 (2007) 105-107
11. Awouters F.H.L., and Lewi P.J.L. Forty years of antipsychotic drug research- from haloperidol to paliperidone- with Dr. Paul Janssen. Arzneim.-Forsch. (Drug Res.) 57 (2007) 625-632
12. Heeres J., and Lewi P.J.L. The medicinal chemistry of the DATA and DAPY series of HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs). In: De Clercq E. (Ed). Advances in Antiviral Drug Design (2007), Elsevier 213-242
13. Hughes S. An unconventional approach to research. Scrip. Mag. (1993) 32-33
14. Lewi P.J., and Smith A. Successful pharmaceutical discovery: Paul Janssen's concept of drug research. R&D Manage. 37 (2007) 355-362
15. Strogatz S. SYNC, The Emerging Science of Spontaneous Order (2003), Hyperion pp. 152-176
16. Kubinyi H. Drug research: myths, hype and reality. Nat. Rev. Drug Disc. 2 (2003) 665-668
17. White J. Creating a productive R&D culture. Drug Disc. Today 6 (2005) 25-29
18. Janssen P.A.J. Drug research. Rev. Méd. Bruxelles 1 (1980) 643-645
19. Janssen P.A.J. The four pillars of effective drug research. Clin. Res. Rev. 1 (1981) 87-89
20. Janssen P.A.J. The effect on choice of research. In: Cavalla J.F. (Ed). Risk-Benefit Analysis in Drug Research (1981), MTP Press 93-95
21. Drews J. Strategic trends in the drug industry. Drug Disc. Today 8 (2003) 411-420
22. Churchill, W.L.S. (1940) Speech before the House of Commons, London, June 18 http://www.winstonchurchill.org/i4a/pages/index.cfm?pageid=418